Revolutionary Bleeding Control Technology
Raising the bar on performance — worldwide.
![](https://cdn.prod.website-files.com/65315329e28538e3f531ea89/65777dc9ec15f116c7c77176_MedcuraInvestors.jpg)
Transforming the global hemostasis market
The global hemostasis market is large, growing and ripe for new transformational technologies.
We are pioneering an unoccupied market segment of “High Safety & Efficacy with Low Cost” hemostasis products. LifeGel™, our flagship flowable hemostat, is ready for pivotal FDA-mandated GLP studies and US human trials in early 2024.
![](https://cdn.prod.website-files.com/65315329e28538e3f531ea89/65c6416465e74c1a7ddf5e3c_InvestorPage2.jpg)
ROBUST SURGICAL PLATFORM EXPANSION PIPELINE
Meet THe team
Get to know the scientists, surgeons, and business development experts behind our success.
![](https://cdn.prod.website-files.com/65315329e28538e3f531ea89/66218b9523d74edca388420f_MCI-Team-web2.jpg)